Gillian C. Ivers-Read
2017
In 2017, Gillian C. Ivers-Read earned a total compensation of $2.4M as EVP of Technical Operations and Chief Regulatory Officer at Clovis Oncology, a 22% increase compared to previous year.
Compensation breakdown
| Bonus | $226,216 |
|---|---|
| Option Awards | $1,011,688 |
| Salary | $435,003 |
| Stock Awards | $683,100 |
| Other | $27,872 |
| Total | $2,383,879 |
Ivers-Read received $1M in option awards, accounting for 42% of the total pay in 2017.
Ivers-Read also received $226.2K in bonus, $435K in salary, $683.1K in stock awards and $27.9K in other compensation.
Rankings
In 2017, Gillian C. Ivers-Read's compensation ranked 4,667th out of 14,666 executives tracked by ExecPay. In other words, Ivers-Read earned more than 68.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,667 out of 14,666 | 68th |
Division Manufacturing | 1,645 out of 5,768 | 72nd |
Major group Chemicals And Allied Products | 478 out of 2,074 | 77th |
Industry group Drugs | 369 out of 1,730 | 79th |
Industry Pharmaceutical Preparations | 291 out of 1,329 | 78th |
Source: SEC filing on April 27, 2018.
Ivers-Read's colleagues
We found four more compensation records of executives who worked with Gillian C. Ivers-Read at Clovis Oncology in 2017.
2017
Patrick Mahaffy
Clovis Oncology
Chief Executive Officer
2017
Lindsey Rolfe
Clovis Oncology
Chief Medical Officer
2017
C Hooks
Clovis Oncology
Senior VP and Chief Commercial Officer
2017
Daniel Muehl
Clovis Oncology
Senior VP of Finance, Principal Accounting Officer, and Principal Financial Officer
News
Clovis Oncology CEO Patrick Mahaffy's 2021 pay slips 18% to $2.6M
April 27, 2022
Clovis Oncology CEO Patrick Mahaffy's 2020 pay falls 53% to $3.2M
April 28, 2021
Clovis Oncology CEO Patrick Mahaffy's 2019 pay rises 10% to $6.9M
April 24, 2020
Clovis Oncology CEO Patrick Mahaffy's 2018 pay falls 28% to $6.3M
April 26, 2019